Yoga for Adolescent and Young Adult Non-Curative Cancer Patients
Impact of Yoga on Quality of Life for Adolescent and Young Adult Non-Curative Cancer Patients: A Pilot Study
1 other identifier
interventional
5
1 country
1
Brief Summary
Adolescents and young adults who are living with cancer are not benefiting from the same age-appropriate physical and psychosocial care, as are children and older adults. As a result, their unique needs often go unmet or unaddressed. Studies have demonstrated that a lack of age-appropriate care may be responsible for a deceased quality of life. Studies have also shown that physical activity is able to reduce many of the negative side-effects linked to cancer and its treatment (e.g., nausea, vomiting, fatigue). A light form of physical activity that is both safe and manageable for cancer patients is yoga. The purpose of this study is to examine the achievability and safety of a light 7-week home/hospice-based Hatha yoga program (available on DVD) in the adolescent and young adult non-curative cancer population. This study will also examine the ability of yoga to reduce cancer related side effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2013
CompletedFirst Posted
Study publicly available on registry
July 17, 2013
CompletedStudy Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 13, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 13, 2017
CompletedJuly 13, 2017
July 1, 2017
3.8 years
July 11, 2013
July 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Feasibility: Recruitment
Recruitment will be calculated by the number of patients who consent to participate, divided by the number of eligible participants recommended by the primary oncologist/physician.
Final: end of week 7
Feasibility: Retention
Retention: Will be determined by reporting the number of participants who complete the baseline and post-program questionnaire and follow-up testing.
Final: end of week 7
Feasibility: Adherence
Adherence: Participants will be asked to record the number of yoga sessions performed each week. Overall adherence will be calculated by summing the actual number of sessions the participant engaged in, divided by the recommended number of sessions.
Final: end of week 7
Safety
Safety: Any adverse events reported by the participant will be recorded.
Final: end of week 7
Secondary Outcomes (1)
Changes in Quality of Life
Baseline: week 1; Final: week 7
Study Arms (1)
Hatha Yoga Program
OTHERSingle-arm pilot study of a 7-week home/hospice-based Hatha yoga program for adolescent and young adults with non-curative cancer.
Interventions
This is a 7-week home/hospice-based instructive Hatha yoga program (available on DVD) for adolescent and young adults diagnosed with a non-curative cancer. Participants will be asked to complete a minimum of one, 75-minute yoga session per week. The DVD package includes four discs that increase in difficulty over the course of the 7-week program. The DVD focuses on postures and breathing exercises. Participants will be asked to keep track of the number and duration of yoga sessions completed over the 7-week period.
Eligibility Criteria
You may qualify if:
- Diagnosed with a non-curative cancer and assigned to non-curative or palliative care
- Between 15-39 years of age
- Have primary physician/oncologist consent to participate
You may not qualify if:
- Experience any medical conditions that contraindicate yoga (e.g., bone metastases)
- Exhibit cognitive limitations (e.g., psychiatric disorders)
- Score below 30% on Palliative Performance Status Scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rob Rutledgelead
- Dalhousie Universitycollaborator
- IWK Health Centrecollaborator
- Nova Scotia Health Authoritycollaborator
Study Sites (1)
Dalhousie University
Halifax, Nova Scotia, B3H 4R2, Canada
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rob Rutledge, MD, FRCPC
Capital District Health Authority, Halifax, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor, Department of Medicine, Dalhousie University
Study Record Dates
First Submitted
July 11, 2013
First Posted
July 17, 2013
Study Start
September 1, 2013
Primary Completion
June 13, 2017
Study Completion
June 13, 2017
Last Updated
July 13, 2017
Record last verified: 2017-07